UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 931

Sortiert nach

Olanzapine for chemotherapy-induced nausea and vomiting control – Authors’ reply

The lancet oncology, 2024-05, Vol.25 (5), p.e177-e177

2024

Volltextzugriff (PDF)

Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update

South Asian journal of cancer, 2019-01, Vol.8 (1), p.01-17

Prabhash, Kumar

2019

Volltextzugriff (PDF)

Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial

Journal of clinical oncology, 2021-04, Vol.39 (11), p.1234-1242

2021

Volltextzugriff (PDF)

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR -Mutated Lung Cancer

Journal of clinical oncology, 2020-01, Vol.38 (2), p.124-136

2020

Volltextzugriff (PDF)

Inhibiting the microglia activation improves the spatial memory and adult neurogenesis in rat hippocampus during 48 h of sleep deprivation

Journal of neuroinflammation, 2017-11, Vol.14 (1), p.222-18, Article 222

2017

Volltextzugriff (PDF)

Macrophage Heterogeneity and Efferocytosis: Beyond the M1/M2 Dichotomy

Circulation research, 2024-01, Vol.134 (2), p.186

2024

Volltextzugriff (PDF)

Combined 177Lu‐PSMA‐617 PRLT and abiraterone acetate versus 177Lu‐PSMA‐617 PRLT monotherapy in metastatic castration‐resistant prostate cancer: An observational study comparing the response and durability

The Prostate, 2021-11, Vol.81 (15), p.1225-1234

2021

Volltextzugriff (PDF)

Weekly versus 3‐weekly cisplatin along with radiotherapy for locoregionally advanced non‐nasopharyngeal head and neck cancers: Is the equipoise in literature addressed yet?

Head & neck, 2023-06, Vol.45 (6), p.1594-1603

2023

Volltextzugriff (PDF)

Corilagin in Cancer: A Critical Evaluation of Anticancer Activities and Molecular Mechanisms

Molecules (Basel, Switzerland), 2019-09, Vol.24 (18), p.3399

2019

Volltextzugriff (PDF)

Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta‐Analysis of Aggregate Data

The oncologist (Dayton, Ohio), 2017-09, Vol.22 (9), p.1056-1066

2017

Volltextzugriff (PDF)

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

The Lancet (British edition), 2014-08, Vol.384 (9944), p.665-673

2014

Volltextzugriff (PDF)

Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer

Journal of clinical oncology, 2019-11, Vol.37 (32), p.3032-3041

2019

Volltextzugriff (PDF)

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

Cancer, 2019-09, Vol.125 (18), p.3184-3197

2019

Volltextzugriff (PDF)

Screening for Lung Cancer in India: Expert Opinion Statement

Journal of the Association of Physicians of India, 2024-05, Vol.72 (5), p.e1-e16

2024

Volltextzugriff (PDF)

Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: A randomized controlled trial

Radiotherapy and oncology, 2012-09, Vol.104 (3), p.343-348

2012

Volltextzugriff (PDF)

Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID‐19 pandemic

Head & neck, 2020-06, Vol.42 (6), p.1173-1178

2020

Volltextzugriff (PDF)

Identification of Rare EIF3E::RSPO2 Fusion in Recurrent and Aggressive Urachal Adenocarcinoma

Genes chromosomes & cancer, 2024-06, Vol.63 (6), p.e23250-n/a

2024

Volltextzugriff (PDF)

Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial

Radiation oncology (London, England), 2020-09, Vol.15 (1), p.1-218, Article 218

2020

Volltextzugriff (PDF)

Superpixel based robust reversible data hiding scheme exploiting Arnold transform with DCT and CA

Journal of King Saud University. Computer and information sciences, 2022-07, Vol.34 (7), p.4402-4420

2022

Volltextzugriff (PDF)

Distress Screening in Head and Neck Cancer Patients Planned for Cancer‐Directed Radiotherapy

The Laryngoscope, 2021-09, Vol.131 (9), p.2023-2029

2021

Volltextzugriff (PDF)

Authors’ reply to Pai and Varghese, and Kenkre et al

Cancer research, statistics, and treatment (Online), 2024, Vol.7 (1), p.142-143

2024

Volltextzugriff (PDF)

1 – 25 von 931

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(824)
Mit Volltextzugriff
(899)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Olanzapine for chemotherapy-induced nausea and vomiting control – Authors’ reply

Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update

Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR -Mutated Lung Cancer

Inhibiting the microglia activation improves the spatial memory and adult neurogenesis in rat hippocampus during 48 h of sleep deprivation

Macrophage Heterogeneity and Efferocytosis: Beyond the M1/M2 Dichotomy

Combined 177Lu‐PSMA‐617 PRLT and abiraterone acetate versus 177Lu‐PSMA‐617 PRLT monotherapy in metastatic castration‐resistant prostate cancer: An observational study comparing the response and durability

Weekly versus 3‐weekly cisplatin along with radiotherapy for locoregionally advanced non‐nasopharyngeal head and neck cancers: Is the equipoise in literature addressed yet?

Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial

Corilagin in Cancer: A Critical Evaluation of Anticancer Activities and Molecular Mechanisms

Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta‐Analysis of Aggregate Data

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study

Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer

Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

Screening for Lung Cancer in India: Expert Opinion Statement

Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: A randomized controlled trial

Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial

Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID‐19 pandemic

Identification of Rare EIF3E::RSPO2 Fusion in Recurrent and Aggressive Urachal Adenocarcinoma

Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial

Superpixel based robust reversible data hiding scheme exploiting Arnold transform with DCT and CA

Distress Screening in Head and Neck Cancer Patients Planned for Cancer‐Directed Radiotherapy

Authors’ reply to Pai and Varghese, and Kenkre et al

Suchergebnisse filtern